|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th Edition) Content
|-
|-
−
!Disease (5th Edition)!!Page Type!!Author (5th Edition)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review (5th Edition)!!Notes (5th Edition)
+
!Disease (5th Edition)!!Page Type!!Author (5th Edition) (Note: please indicate trainees in parentheses)!!Date Assigned to Author (5th Edition)!!Target Completion Date (5th Edition)!!Content Status (5th Edition)(Pending or Complete)!!Date Completed by Author (5th Edition)!!Associate Editor!!Date of Last Editor Review (5th Edition)!!Notes (5th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Disease Name (4th Edition)
!Correlated Prior Author (4th Edition)
!Correlated Prior Author (4th Edition)
Line 560:
Line 560:
|Myeloid neoplasm post cytotoxic therapy
|Myeloid neoplasm post cytotoxic therapy
|Disease
|Disease
−
|Shawn A. Silver, DO, Shashi Shetty, Ph.D.
+
|
|
|
|
|
Line 568:
Line 568:
|
|
|
|
+
|Therapy-Related Myeloid Neoplasms
+
|Shawn A. Silver, DO, Shashi Shetty, Ph.D.
|
|
|
|
−
|
+
|Check reference format
−
|
−
|
|-
|-
|Myeloid neoplasms associated with germline predisposition
|Myeloid neoplasms associated with germline predisposition